Verona Pharma plc Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2020 to Q2 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Verona Pharma plc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q2 2024.
- Verona Pharma plc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$70.8M, a 704% decline year-over-year.
- Verona Pharma plc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$125M, a 143% decline year-over-year.
- Verona Pharma plc annual Net Income (Loss) Attributable to Parent for 2023 was -$54.4M, a 20.9% increase from 2022.
- Verona Pharma plc annual Net Income (Loss) Attributable to Parent for 2022 was -$68.7M, a 23.6% decline from 2021.
- Verona Pharma plc annual Net Income (Loss) Attributable to Parent for 2021 was -$55.6M, a 14.7% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)